Macromol. Biosci. 3/2016

Macromol. Biosci. 3/2016

Back Cover: Defined poly(2‐oxazoline)s (POx) bearing a maleimide terminal function was conjugated with hydrophilic elastin‐like polypeptides (ELP) in a straightforward Michael‐addition reaction. The first example to use the amphiphilic POx‐ELP hybrids as a polymer therapeutic by the formulation of a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Macromolecular bioscience 2016-03, Vol.16 (3), p.464-464
Hauptverfasser: Nawroth, Jonas F., McDaniel, Jonathan R., Chilkoti, Ashutosh, Jordan, Rainer, Luxenhofer, Robert
Format: Artikel
Sprache:eng
Schlagworte:
bioconjugation
drug delivery systems
elastin-like polypeptides
paclitaxel
ring-opening polymerization
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 464
container_issue 3
container_start_page 464
container_title Macromolecular bioscience
container_volume 16
creator Nawroth, Jonas F.
McDaniel, Jonathan R.
Chilkoti, Ashutosh
Jordan, Rainer
Luxenhofer, Robert
description Back Cover: Defined poly(2‐oxazoline)s (POx) bearing a maleimide terminal function was conjugated with hydrophilic elastin‐like polypeptides (ELP) in a straightforward Michael‐addition reaction. The first example to use the amphiphilic POx‐ELP hybrids as a polymer therapeutic by the formulation of a hydrophobic anti‐cancer drug (paclitaxel) is shown. Further details can be found in the article by J. F. Nawroth, J. R. McDaniel, A. Chilkoti, R. Jordan, R. Luxenhofer on page 322.
doi_str_mv 10.1002/mabi.201670014
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1776666779</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1776666779</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2004-b4bde57abc2687c1288f04b4573fb5d45dfc585f73ded504aa4584e095bafa333</originalsourceid><addsrcrecordid>eNqFkMFPwjAUhxujiYhejUeOXjbatd3rjkBkEEE5YEi8NG3XJtXN4QpR_ntHZog33-W9w_f98vJD6JbgmGCcDCulfZxgkgLGhJ2hHklJGnGS8fPTLeASXYXw1hIgsqSH7pbKNHVVl_Fg7OtgfDygw2PINbpwqgz25nf30cv0YT2ZRYvnfD4ZLSKTYMwizXRhOShtklSAIYkQDjPNOFCnecF44QwX3AEtbMExU4pxwSzOuFZOUUr76L7L3Tb1596Gnax8MLYs1Yet90ESgLQdgKxF4w5tPw6hsU5uG1-p5iAJlscK5LECeaqgFbJO-PKlPfxDy-VoPP_rRp3rw85-n1zVvMsUKHC5ecrlarZ5XL_mK0npD2Jva-I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1776666779</pqid></control><display><type>article</type><title>Macromol. Biosci. 3/2016</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Nawroth, Jonas F. ; McDaniel, Jonathan R. ; Chilkoti, Ashutosh ; Jordan, Rainer ; Luxenhofer, Robert</creator><creatorcontrib>Nawroth, Jonas F. ; McDaniel, Jonathan R. ; Chilkoti, Ashutosh ; Jordan, Rainer ; Luxenhofer, Robert</creatorcontrib><description>Back Cover: Defined poly(2‐oxazoline)s (POx) bearing a maleimide terminal function was conjugated with hydrophilic elastin‐like polypeptides (ELP) in a straightforward Michael‐addition reaction. The first example to use the amphiphilic POx‐ELP hybrids as a polymer therapeutic by the formulation of a hydrophobic anti‐cancer drug (paclitaxel) is shown. Further details can be found in the article by J. F. Nawroth, J. R. McDaniel, A. Chilkoti, R. Jordan, R. Luxenhofer on page 322.</description><identifier>ISSN: 1616-5187</identifier><identifier>EISSN: 1616-5195</identifier><identifier>DOI: 10.1002/mabi.201670014</identifier><language>eng</language><publisher>Blackwell Publishing Ltd</publisher><subject>bioconjugation ; drug delivery systems ; elastin-like polypeptides ; paclitaxel ; ring-opening polymerization</subject><ispartof>Macromolecular bioscience, 2016-03, Vol.16 (3), p.464-464</ispartof><rights>2016 WILEY‐VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fmabi.201670014$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fmabi.201670014$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids></links><search><creatorcontrib>Nawroth, Jonas F.</creatorcontrib><creatorcontrib>McDaniel, Jonathan R.</creatorcontrib><creatorcontrib>Chilkoti, Ashutosh</creatorcontrib><creatorcontrib>Jordan, Rainer</creatorcontrib><creatorcontrib>Luxenhofer, Robert</creatorcontrib><title>Macromol. Biosci. 3/2016</title><title>Macromolecular bioscience</title><addtitle>Macromol. Biosci</addtitle><description>Back Cover: Defined poly(2‐oxazoline)s (POx) bearing a maleimide terminal function was conjugated with hydrophilic elastin‐like polypeptides (ELP) in a straightforward Michael‐addition reaction. The first example to use the amphiphilic POx‐ELP hybrids as a polymer therapeutic by the formulation of a hydrophobic anti‐cancer drug (paclitaxel) is shown. Further details can be found in the article by J. F. Nawroth, J. R. McDaniel, A. Chilkoti, R. Jordan, R. Luxenhofer on page 322.</description><subject>bioconjugation</subject><subject>drug delivery systems</subject><subject>elastin-like polypeptides</subject><subject>paclitaxel</subject><subject>ring-opening polymerization</subject><issn>1616-5187</issn><issn>1616-5195</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqFkMFPwjAUhxujiYhejUeOXjbatd3rjkBkEEE5YEi8NG3XJtXN4QpR_ntHZog33-W9w_f98vJD6JbgmGCcDCulfZxgkgLGhJ2hHklJGnGS8fPTLeASXYXw1hIgsqSH7pbKNHVVl_Fg7OtgfDygw2PINbpwqgz25nf30cv0YT2ZRYvnfD4ZLSKTYMwizXRhOShtklSAIYkQDjPNOFCnecF44QwX3AEtbMExU4pxwSzOuFZOUUr76L7L3Tb1596Gnax8MLYs1Yet90ESgLQdgKxF4w5tPw6hsU5uG1-p5iAJlscK5LECeaqgFbJO-PKlPfxDy-VoPP_rRp3rw85-n1zVvMsUKHC5ecrlarZ5XL_mK0npD2Jva-I</recordid><startdate>201603</startdate><enddate>201603</enddate><creator>Nawroth, Jonas F.</creator><creator>McDaniel, Jonathan R.</creator><creator>Chilkoti, Ashutosh</creator><creator>Jordan, Rainer</creator><creator>Luxenhofer, Robert</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>201603</creationdate><title>Macromol. Biosci. 3/2016</title><author>Nawroth, Jonas F. ; McDaniel, Jonathan R. ; Chilkoti, Ashutosh ; Jordan, Rainer ; Luxenhofer, Robert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2004-b4bde57abc2687c1288f04b4573fb5d45dfc585f73ded504aa4584e095bafa333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>bioconjugation</topic><topic>drug delivery systems</topic><topic>elastin-like polypeptides</topic><topic>paclitaxel</topic><topic>ring-opening polymerization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nawroth, Jonas F.</creatorcontrib><creatorcontrib>McDaniel, Jonathan R.</creatorcontrib><creatorcontrib>Chilkoti, Ashutosh</creatorcontrib><creatorcontrib>Jordan, Rainer</creatorcontrib><creatorcontrib>Luxenhofer, Robert</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Macromolecular bioscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nawroth, Jonas F.</au><au>McDaniel, Jonathan R.</au><au>Chilkoti, Ashutosh</au><au>Jordan, Rainer</au><au>Luxenhofer, Robert</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Macromol. Biosci. 3/2016</atitle><jtitle>Macromolecular bioscience</jtitle><addtitle>Macromol. Biosci</addtitle><date>2016-03</date><risdate>2016</risdate><volume>16</volume><issue>3</issue><spage>464</spage><epage>464</epage><pages>464-464</pages><issn>1616-5187</issn><eissn>1616-5195</eissn><abstract>Back Cover: Defined poly(2‐oxazoline)s (POx) bearing a maleimide terminal function was conjugated with hydrophilic elastin‐like polypeptides (ELP) in a straightforward Michael‐addition reaction. The first example to use the amphiphilic POx‐ELP hybrids as a polymer therapeutic by the formulation of a hydrophobic anti‐cancer drug (paclitaxel) is shown. Further details can be found in the article by J. F. Nawroth, J. R. McDaniel, A. Chilkoti, R. Jordan, R. Luxenhofer on page 322.</abstract><pub>Blackwell Publishing Ltd</pub><doi>10.1002/mabi.201670014</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1616-5187
ispartof Macromolecular bioscience, 2016-03, Vol.16 (3), p.464-464
issn 1616-5187
1616-5195
language eng
recordid cdi_proquest_miscellaneous_1776666779
source Wiley Online Library Journals Frontfile Complete
subjects bioconjugation
drug delivery systems
elastin-like polypeptides
paclitaxel
ring-opening polymerization
title Macromol. Biosci. 3/2016
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T21%3A30%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Macromol.%20Biosci.%203/2016&rft.jtitle=Macromolecular%20bioscience&rft.au=Nawroth,%20Jonas%20F.&rft.date=2016-03&rft.volume=16&rft.issue=3&rft.spage=464&rft.epage=464&rft.pages=464-464&rft.issn=1616-5187&rft.eissn=1616-5195&rft_id=info:doi/10.1002/mabi.201670014&rft_dat=%3Cproquest_cross%3E1776666779%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1776666779&rft_id=info:pmid/&rfr_iscdi=true